IN2012DN03257A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03257A IN2012DN03257A IN3257DEN2012A IN2012DN03257A IN 2012DN03257 A IN2012DN03257 A IN 2012DN03257A IN 3257DEN2012 A IN3257DEN2012 A IN 3257DEN2012A IN 2012DN03257 A IN2012DN03257 A IN 2012DN03257A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24503609P | 2009-09-23 | 2009-09-23 | |
| PCT/US2010/049843 WO2011038014A2 (en) | 2009-09-23 | 2010-09-22 | Composition and method for treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN03257A true IN2012DN03257A (en) | 2015-10-23 |
Family
ID=43796466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3257DEN2012 IN2012DN03257A (en) | 2009-09-23 | 2012-04-16 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9301938B2 (en) |
| EP (1) | EP2480246A4 (en) |
| JP (1) | JP2013505936A (en) |
| KR (1) | KR20120082003A (en) |
| CN (1) | CN102711800A (en) |
| AU (1) | AU2010298303A1 (en) |
| BR (1) | BR112012006437A2 (en) |
| CA (1) | CA2774616A1 (en) |
| CL (1) | CL2012000713A1 (en) |
| EA (1) | EA201290158A1 (en) |
| IN (1) | IN2012DN03257A (en) |
| MX (1) | MX2012003459A (en) |
| WO (1) | WO2011038014A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2364161B1 (en) * | 2008-11-26 | 2020-03-11 | Satiogen Pharmaceuticals, Inc. | Compositions containing satiogens and methods of use |
| JP6089042B2 (en) * | 2011-11-21 | 2017-03-01 | エマウス メディカル インコーポレイテッド | Methods and compositions for the treatment of diabetes and related conditions |
| US20150073057A1 (en) * | 2013-09-06 | 2015-03-12 | Biokier, Inc. | Composition and method for treatment of diabetes |
| JOP20190146A1 (en) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | Amino acid compositions and methods for the treatment of liver diseases |
| BR112019021742A2 (en) | 2017-04-17 | 2020-05-05 | Univ Chicago | composition, system, pharmaceutical composition, food or nutraceutical composition, method and use of the composition |
| WO2019165309A1 (en) | 2018-02-23 | 2019-08-29 | Ambra Bioscience Llc | Compositions and methods for hunger control and weight management |
| AR115585A1 (en) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FAT INFILTRATION IN MUSCLE |
| US20200262887A1 (en) | 2018-11-30 | 2020-08-20 | Opko Ireland Global Holdings, Ltd. | Oxyntomodulin peptide analog formulations |
| US20210267919A1 (en) * | 2020-02-28 | 2021-09-02 | Biokier, Inc. | Stabilized coated butyrate for colon release |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1245890B (en) * | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | PHARMACEUTICAL FORMULATIONS FOR ORAL USE GASTRORESANTS CONTAINING BILE ACIDS. |
| PT1003476E (en) | 1997-08-11 | 2005-05-31 | Alza Corp | ACTIVE AGGREGATE AGGREGATE DOSAGE FORM ADAPTED FOR GASTRIC RETENTION |
| US6652882B1 (en) | 1997-10-06 | 2003-11-25 | Intellipharmaceutics Corp | Controlled release formulation containing bupropion |
| GB9722426D0 (en) | 1997-10-23 | 1997-12-24 | Univ London Pharmacy | Controlled release formulations |
| US7431943B1 (en) | 1999-06-14 | 2008-10-07 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical compositions |
| ATE396738T1 (en) | 2000-09-18 | 2008-06-15 | Sanos Bioscience As | USE OF GLP-2 PEPTIDES |
| CA2438593C (en) | 2001-02-26 | 2010-09-21 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| US20030203004A1 (en) | 2002-04-24 | 2003-10-30 | Kelm Gary Robert | Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| US20040122033A1 (en) * | 2002-12-10 | 2004-06-24 | Nargund Ravi P. | Combination therapy for the treatment of obesity |
| DE60300502T2 (en) | 2003-10-28 | 2006-02-23 | Adorkem Technology S.P.A., Costa Volpino | Process for the preparation of citalopram |
| ITMI20040187A1 (en) | 2004-02-06 | 2004-05-06 | Cosmo Spa | PHARMACEUTICAL OR DIETETIC COMPOSITIONS BASED ON SHORT CHAIN FATTY ACIDS AND COMPLEX SUGARS FOR INTESTINAL DYSFUNCTIONS |
| JP2006006304A (en) | 2004-06-24 | 2006-01-12 | Emiko Nanri | Dung receiver for dog |
| ITMI20041295A1 (en) | 2004-06-25 | 2004-09-25 | Cosmo Spa | ORAL ANTI-MICROBIAL PHARMACEUTICAL COMPOSITIONS |
| JP2006056881A (en) | 2004-07-21 | 2006-03-02 | Takeda Chem Ind Ltd | Fused ring compound |
| AU2006250354A1 (en) | 2005-05-23 | 2006-11-30 | Japan Tobacco Inc. | Pyrazole compound and therapeutic agent for diabetes comprising the same |
| DE102005046237A1 (en) | 2005-09-28 | 2007-04-05 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Use of butyrate esters of carbohydrates or carbohydrate polyols as butyrate source for the digestive tract, useful for prevention and treatment of gastrointestinal diseases in humans and animals |
| ITMI20052000A1 (en) | 2005-10-21 | 2007-04-22 | Promefarm S R L | GASTRORESITENT TABLET BASED ON SODIUM BUTIRRATE |
| KR20080080593A (en) * | 2005-11-30 | 2008-09-04 | 에프. 호프만-라 로슈 아게 | Methods for synthesis of 3-amino-1-arylpropyl indoles |
| JP2009530231A (en) | 2006-01-20 | 2009-08-27 | スミスクライン ビーチャム コーポレーション | Use of sulfonamide derivatives in the treatment of metabolic and nervous system diseases |
| WO2008067219A2 (en) | 2006-11-29 | 2008-06-05 | Kalypsys, Inc. | Quinazolinone modulators of tgr5 |
| KR101487852B1 (en) | 2006-12-15 | 2015-01-29 | 티마 파운데이션 | Novel compositions and uses thereof |
| CN102316872B (en) | 2008-11-26 | 2016-12-21 | 萨蒂奥根制药公司 | Treatment obesity and the bile acid recycling inhibitors of diabetes |
| EP2364161B1 (en) | 2008-11-26 | 2020-03-11 | Satiogen Pharmaceuticals, Inc. | Compositions containing satiogens and methods of use |
| LT2596786T (en) | 2009-02-10 | 2020-01-10 | Amarin Pharmaceuticals Ireland Limited | Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia |
| NZ620473A (en) | 2009-06-15 | 2015-09-25 | Amarin Pharmaceuticals Ie Ltd | Compositions and methods for lowering triglycerides without raising ldl-c levels |
| NZ599061A (en) | 2009-09-23 | 2014-05-30 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
-
2010
- 2010-09-22 EA EA201290158A patent/EA201290158A1/en unknown
- 2010-09-22 WO PCT/US2010/049843 patent/WO2011038014A2/en active Application Filing
- 2010-09-22 MX MX2012003459A patent/MX2012003459A/en not_active Application Discontinuation
- 2010-09-22 BR BR112012006437A patent/BR112012006437A2/en not_active Application Discontinuation
- 2010-09-22 CN CN2010800530328A patent/CN102711800A/en active Pending
- 2010-09-22 US US13/497,114 patent/US9301938B2/en active Active
- 2010-09-22 AU AU2010298303A patent/AU2010298303A1/en not_active Abandoned
- 2010-09-22 EP EP20100819399 patent/EP2480246A4/en not_active Withdrawn
- 2010-09-22 CA CA2774616A patent/CA2774616A1/en not_active Abandoned
- 2010-09-22 JP JP2012530996A patent/JP2013505936A/en active Pending
- 2010-09-22 KR KR1020127009900A patent/KR20120082003A/en not_active Application Discontinuation
-
2012
- 2012-03-22 CL CL2012000713A patent/CL2012000713A1/en unknown
- 2012-04-16 IN IN3257DEN2012 patent/IN2012DN03257A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9301938B2 (en) | 2016-04-05 |
| CA2774616A1 (en) | 2011-03-31 |
| WO2011038014A2 (en) | 2011-03-31 |
| BR112012006437A2 (en) | 2016-04-19 |
| CL2012000713A1 (en) | 2012-08-10 |
| AU2010298303A1 (en) | 2012-04-12 |
| WO2011038014A3 (en) | 2011-08-11 |
| EP2480246A4 (en) | 2013-02-27 |
| EP2480246A2 (en) | 2012-08-01 |
| JP2013505936A (en) | 2013-02-21 |
| MX2012003459A (en) | 2012-05-22 |
| CN102711800A (en) | 2012-10-03 |
| KR20120082003A (en) | 2012-07-20 |
| EA201290158A1 (en) | 2012-08-30 |
| US20120183617A1 (en) | 2012-07-19 |